Minerva Neurosciences Q4 EPS $(1.19) Misses $(0.88) Estimate; Cash, Cash Equivalents And Restricted Cash Were Approximately $41M
Portfolio Pulse from Benzinga Newsdesk
Minerva Neurosciences (NASDAQ:NERV) reported a Q4 EPS loss of $1.19, missing the consensus estimate of $0.88 by 35.23%. This represents a slight improvement over the previous year's loss of $1.26 per share. The company also reported having approximately $41M in cash, cash equivalents, and restricted cash.
February 22, 2024 | 12:24 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Minerva Neurosciences reported a larger than expected Q4 EPS loss of $1.19, missing the consensus estimate of $0.88. However, this is an improvement from the previous year's loss of $1.26 per share. The company's cash position is reported at approximately $41M.
The reported EPS miss is likely to negatively impact investor sentiment in the short term, as it indicates a larger than expected loss. However, the slight improvement over last year's loss and the company's cash position may provide some support to the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100